Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 7;193(23):E854-E855.
doi: 10.1503/cmaj.210140.

Refocusing on hypertension control in Canada

Alexander A Leung  1 , Alan Bell  2 , Ross T Tsuyuki  2 , Norman R C Campbell  2
Affiliations

Refocusing on hypertension control in Canada

Alexander A Leung et al. CMAJ. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: Alexander Leung was involved in the development of the Hypertension Canada clinical practice guidelines (2016–2020) and is cochair of Hypertension Canada’s research and evaluation committee. He also reports grants from the Canadian Institutes of Health Research and Hypertension Canada, outside the submitted work. Alan Bell is a member of the board of directors of Hypertension Canada, cochair of the implementation and education committee (2016–present) and coauthor of the clinical practice guidelines (2020). Ross Tsuyuki is the president of Hypertension Canada (2020–present), cochair of the implementation and education committee (2017–present), member of the Implementation Research Task Force (2005–2011) and the Public Recommendations Task Force (2007–2010), and editor-in-chief of the Canadian Pharmacists Journal. He also reports consulting fees from Emergent Biosolutions, Shoppers Drug Mart and HLS Therapeutics, as well as an honorarium from Sanofi Genzyme. Norman Campbell is past president and special advisor to the board of the World Hypertension League, and is vice chair of the Canadian Hypertension Advisory Committee. He reports support from Resolve to Save Lives, World Bank, the Pan American Health Organization and the World Health Organization related to involvement in hypertension control programs. He is also a consultant to the Hearts in the Americas Initiative of the Pan American Health Organization (2012–present), and a reviewer of the World Health Organization Hearts Program (2014–present). No other competing interests were declared.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Joffres M, Falaschetti E, Gillespie C, et al. . Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study. BMJ Open 2013;3:e003423. - PMC - PubMed
    1. Leung AA, Williams JVA, McAlister FA, et al. . Worsening hypertension awareness, treatment, and control rates in Canadian women between 2007 and 2017. Can J Cardiol 2020;36:732–9. - PubMed
    1. Global burden of disease study. Seattle (WA): University of Washington, Institute for Health Metrics and Evaluation; 2017. Available: http://vizhub.healthdata.org/gbd-compare (accessed 2021 Jan. 19).
    1. Beckett NS, Peters R, Fletcher AE, et al. . Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008;358:1887–98. - PubMed
    1. Williamson JD, Supiano MA, Applegate WB, et al. . Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥ 75 years: a randomized clinical trial. JAMA 2016;315:2673–82. - PMC - PubMed